All PlansCoverageMedium impact
Avoid the Inappropriate Use of Antipsychotic Medication in Anxiety Disorders
BCBS Montana·MT · Psychiatry, Family Medicine, Internal Medicine +1 more·General
Effective date
Jan 14, 2026
We identified it
Jun 18, 2026
Summary
Blue Cross Blue Shield of Montana issued guidance discouraging inappropriate use of antipsychotic medications for anxiety disorders, as most antipsychotics are not FDA-approved for anxiety conditions like panic disorder and generalized anxiety disorder. The policy emphasizes evidence-based prescribing and references clinical practice guidelines for proper anxiety disorder treatment.
Action Required
Immediately: Providers prescribing antipsychotic medications should review current anxiety disorder patients to ensure appropriate prescribing according to evidence-based guidelines. Clinical staff should reference the provided behavioral health practice guidelines when treating anxiety disorders and consider alternative treatments before antipsychotics. Document medical necessity and risk-benefit assessment when antipsychotics are prescribed off-label for anxiety.